On May 17, 2022 Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, reported that Jounce management will participate at the following upcoming investor conferences (Press release, Jounce Therapeutics, MAY 17, 2022, View Source [SID1234614750]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Global Investment Conference: Presentation will be available for on-demand viewing starting Tuesday, May 24, 2022 at 7:00 a.m. ET.
Cowen’s 3rd Annual Oncology Innovation Summit: Insights for ASCO (Free ASCO Whitepaper) & EHA (Free EHA Whitepaper): A live presentation will take place virtually on Thursday, June 2, 2022 at 1:30 p.m. ET.
A webcast of each presentation can be accessed by visiting the Investors & Media section of Jounce’ website at View Source A replay of each webcast will be archived on Jounce’s site for 30 days following the event.